Article | February 25, 2023

Emerging Artificial Intelligence And Machine Learnings In Drug Manufacturing

Source: CAI

By Laurent Saugrin


The broad scope of digital health includes categories such as health information technology or wearable devices. Digital health technologies use computing platforms, connectivity, software, and sensors for health care and related uses. Digital tools offer real opportunities to improve medical outcomes and enhance efficiency, and give providers a more holistic view of patient health through access to data.

Within the field of digital health, Artificial Intelligence and Machine Learning (AI/ML) tools and technologies have the potential to transform health care by deriving new and important insights from the vast amount of data generated. However, AI/ML presents the challenge of maintaining overall quality and regulatory compliance of IT systems, applications, and solutions in the the life sciences industry.

GAMP5 Edition 2 introduced the new Appendix D11 – Artificial Intelligence and Machine Learning (AI/ML), which provides guidance on how to ensure compliant integration and fitness for use in a validated environment. Learn more about Artificial Intelligence, Machine Learning, and the new AI/ML Appendix D11.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online